Gynesonics

Redwood City, United States Founded: 2005 • Age: 21 yrs Acquired By Hologic
A minimally invasive ablation system for uterine fibroids is developed.

About Gynesonics

Gynesonics is a Healthcare company based in Redwood City (United States) founded in 2005, and was acquired by Hologic in October 2024. A minimally invasive ablation system for uterine fibroids is developed. It operates on a HealthTech model. Gynesonics has raised $282.54 million across 14 funding rounds from investors including Hologic, Bain Capital and Hercules Capital. The company has 92 employees. Gynesonics offers products and services including Sonata System. Its focus areas include Medical Devices and Women's Health Devices. Its legal entity is Gynesonics, Inc. Its competitors include Channel Medsystems, Minerva Surgical and Interlace Medical; 3 of its 3 listed competitors have raised funding.

Company details

Medical technologies for womens health are advanced by Gynesonics. Solutions for heavy periods and uterine fibroids are provided through minimally invasive procedures. The Sonata System, a transcervical fibroid ablation technology, is offered as a key product. Focus is placed on combining ultrasound guidance with radiofrequency energy. The healthcare sector, specifically womens health, is primarily targeted.

  • Headquarters Redwood City, United States
  • Employees 92
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website gynesonics.com/us
  • Social LinkedIn
  • Acquired by Hologic (Oct 2024)
  • Legal Name Gynesonics, Inc
Key Metrics
  • Total Equity Funding
    $282.54M (USD)

    in 14 rounds

  • Investors
    Hologic

    & 15 more

  • Employee Count
    92
  • Acquired by
    Hologic

    (Oct 2024)

Products & Services of Gynesonics

Gynesonics offers a comprehensive portfolio of products and services, including Sonata System.

Sonata System
Medical Technology

Intrauterine fibroid ablation system using ultrasound-guided radiofrequency.

Funding Insights of Gynesonics

Gynesonics has successfully raised a total of $282.54M across 14 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $282.54M
  • Total Rounds 14
  • First Round $16.5M

    (Jan 2007)

  • Investors Count 15

Latest 10 of 14 funding rounds of Gynesonics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2023Series F–Kaiser Permanente Ventures, Amzak Health
Apr 2023$92.18MSeries F–Amzak Health, Endeavour Vision
Jan 2021$50MDebt – Conventional––
Jan 2019$75.47MSeries F–Bain Capital Life Sciences
Nov 2015$2.9MSeries E–NOVIT Ventures
–
Jul 2015$43.14MSeries E–Endeavour Vision
Apr 2015$3MDebt – Conventional––
–
Jul 2014$28.45MSeries D–HBM Partners
Jan 2013$900,180Series C––
–
Dec 2012$900,181Series C––
–
Valuation history

16 investors in total: 16 institutional.

Investors in Gynesonics

Gynesonics has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, Bain Capital and Hercules Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Tech and Life Sciences focused corporate VC firm investing in the US
kpventures.comOakland, United States
Amzak Health is engaged in venture investments in life sciences.
amzakhealth.comNew York, United States
Endeavour Vision is focused on transformative healthcare technology investments.
endeavourvision.comGeneva, Switzerland
Venture debt financing is provided to companies across multiple sectors.
2015runwaygrowth.comWoodside, United States
Debt and equity investments are pursued across multiple sectors.
1984baincapital.comBoston, United States
Private equity investments in healthcare companies are managed.
1997mvm.comLondon, United Kingdom
Venture capital investments are made in healthcare and technology sectors.
novitventures.comRockville, United States
Early stage venture capital firm investing in US
1973abingworth.comLondon, United Kingdom
Early-stage investing in IT and healthcare ventures.
interwest.com
VC firm making investment in early stage startups in the US
atvcapital.comMenlo Park, United States
Premium access

Investor details for Gynesonics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Gynesonics

25 people are tracked at Gynesonics (8 in leadership, 4 in board & advisors, 13 in team); the tracked headcount is 92.

NameRoleGroup
James Sparks
Senior Vice President Global OperationsLeadership
Jordan Bajor
COOLeadership
Peggy Boer
Director Of MaterialsLeadership
Taraneh G. Farazi
Senior Vice President, R&d, Global Clinical Strategy And Scientific InnovationsLeadership
Richard Lanigan
VP, European Sales & MarketingLeadership
Kelly Petrucci
VP, Healthcare Economics and Marketg AccessLeadership
Robert Brown
CFOLeadership
Ted Stephens
Chief Marketing And Strategy OfficerLeadership
Alexander Schmitz
DirectorBoard & advisors
Joyce Erony
DirectorBoard & advisors
David Pacitti
Independent DirectorBoard & advisors
Greg Greifeld
DirectorBoard & advisors
Daniel Spaner
Regional Sales ManagerTeam
Paul Russo
Regional Sales ManagerTeam
Michael Shacher
Accounting ManagerTeam
Giovanni Guaresi
Territory Manager SwissTeam
Michelle Bunton
Regional Sales ManagerTeam
Jimmy Chen
Sr. BuyerTeam
Jessica Hsueh
Research And Development EngineerTeam
Heather Cupp
Senior Human Resources ManagerTeam

5 more people are available in the full profile.

Premium access

Complete people profiles for Gynesonics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Gynesonics

4 dated milestones of Gynesonics across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Gynesonics is founded.
  2. Funding First funding round of $16.5M.
  3. Funding Latest funding round, Series F,.
  4. Exit Acquired by Hologic.

Competitors of Gynesonics

Gynesonics has 3 listed competitors in our database, 3 of them funded. They include Channel Medsystems, Minerva Surgical and Interlace Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
channelmedsystems.com2009San Francisco, United States$47.67M37
Cryothermic technology for endometrial ablation to control heavy bleeding
minervasurgical.com2008Redwood, United States$135.1M155
Minerva Surgical is focused on uterine health solutions.
interlacemedical.com2006Framingham, United States$32.5M
Gynecological devices for office-based procedures are designed and developed.
Premium access

Detailed competitors of Gynesonics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Gynesonics

The website of Gynesonics (gynesonics.com) receives about 1.5K visits a month.

  • Monthly visits
    1.5K

    ▼ 5% vs previous month

Top companies in Women's Health & Fertility

3 companies that operate in the same segment as Gynesonics (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of cell-free DNA testing for oncology, women’s health, and organ health
2004Redwood City, California, United StatesUSD 152.1 MUSD 2.31 B4,430
Therapeutics for women's healthcare are developed and offered.
1997Princeton, New Jersey, United StatesUSD 123.06 MUSD 19.59 M
Provider of cell-free cancer liquid biopsy test
2015San Francisco, California, United StatesUSD 388.62 M861
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Gynesonics

Premium access

Complete news archive for Gynesonics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gynesonics

Gynesonics was founded in 2005 and raised its 1st funding round 2 years after it was founded.

Gynesonics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

Gynesonics is a funded company, having raised a total of $282.54M across 14 funding rounds to date. The company's 1st funding round was a Series C of $900.18K, raised on Jan 2007.

Gynesonics has 92 employees.

Medical technologies for womens health are advanced by Gynesonics. Solutions for heavy periods and uterine fibroids are provided through minimally invasive procedures. The Sonata System, a transcervical fibroid ablation technology, is offered as a key product. Focus is placed on combining ultrasound guidance with radiofrequency energy. The healthcare sector, specifically womens health, is primarily targeted.

Gynesonics's top competitors include Channel Medsystems, Minerva Surgical and Interlace Medical.

Gynesonics offers Sonata System.

Gynesonics has 16 investors. Key investors include Hologic, Bain Capital, Hercules Capital, Abingworth, and MVM Partners.

Gynesonics operates through Gynesonics, Inc.

Yes. Gynesonics was acquired by Hologic in October 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available